ZA95968B - Interferon alpha/beta binding protein its preparation and use - Google Patents

Interferon alpha/beta binding protein its preparation and use

Info

Publication number
ZA95968B
ZA95968B ZA95968A ZA95968A ZA95968B ZA 95968 B ZA95968 B ZA 95968B ZA 95968 A ZA95968 A ZA 95968A ZA 95968 A ZA95968 A ZA 95968A ZA 95968 B ZA95968 B ZA 95968B
Authority
ZA
South Africa
Prior art keywords
preparation
binding protein
interferon alpha
beta binding
interferon
Prior art date
Application number
ZA95968A
Other languages
English (en)
Inventor
Batya Cohen
Daniela Novick
Menachem Rubinstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of ZA95968B publication Critical patent/ZA95968B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA95968A 1994-02-07 1995-02-07 Interferon alpha/beta binding protein its preparation and use ZA95968B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL108584A IL108584A (en) 1994-02-07 1994-02-07 Cloning of interferon -alpha/beta binding protein

Publications (1)

Publication Number Publication Date
ZA95968B true ZA95968B (en) 1995-10-10

Family

ID=11065792

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA95968A ZA95968B (en) 1994-02-07 1995-02-07 Interferon alpha/beta binding protein its preparation and use

Country Status (17)

Country Link
EP (1) EP0676413B9 (de)
JP (2) JP3670045B2 (de)
KR (1) KR100382628B1 (de)
CN (1) CN1286976C (de)
AT (1) ATE286509T1 (de)
AU (1) AU688430B2 (de)
CA (1) CA2141747C (de)
DE (1) DE69533905T2 (de)
DK (1) DK0676413T3 (de)
ES (1) ES2236696T3 (de)
FI (1) FI118084B (de)
IL (1) IL108584A (de)
NO (1) NO318912B1 (de)
PT (1) PT676413E (de)
RU (4) RU2232811C2 (de)
UA (1) UA46694C2 (de)
ZA (1) ZA95968B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118096A0 (en) * 1996-05-01 1996-09-12 Yeda Res & Dev Antibodies against interferon alpha/beta receptor
US7087726B2 (en) * 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
CN1405181A (zh) * 2001-08-10 2003-03-26 中国人民解放军军事医学科学院生物工程研究所 血清白蛋白与干扰素的融合蛋白
US20070081995A1 (en) * 2005-06-22 2007-04-12 Genentech, Inc. Methods and compositions for targeting IFNAR2
JP5104622B2 (ja) * 2008-07-29 2012-12-19 Ｊｎｃ株式会社 磁性粒子を用いた測定対象物質の濃度測定法
AU2013211059B8 (en) * 2012-01-20 2017-12-21 Centre Hospitalier Regional Universitaire De Montpellier Targeted mutant alpha-helical bundle cytokines
ES2950288T3 (es) * 2016-04-29 2023-10-06 Pfizer Anticuerpos interferón beta y usos de los mismos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
FR2653445B1 (fr) * 1989-10-20 1994-07-29 Centre Nat Rech Scient Fragment d'adnc codant pour le gene du recepteur de l'interferon alpha et procede de preparation d'une proteine correspondante.
AU653937B2 (en) * 1991-04-17 1994-10-20 Medisup International N.V. Water-soluble polypeptides having high affinity for interferons alpha and beta
RU2006036C1 (ru) * 1991-12-27 1994-01-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН Способ определения антигенов
IL106591A (en) * 1992-09-03 2008-03-20 Yeda Res & Dev Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
JPH07298886A (ja) 1995-11-14
EP0676413B1 (de) 2005-01-05
CN1286976C (zh) 2006-11-29
CA2141747A1 (en) 1995-08-08
PT676413E (pt) 2005-05-31
FI950516A0 (fi) 1995-02-06
EP0676413B9 (de) 2005-05-18
CN1109505A (zh) 1995-10-04
JP2005200422A (ja) 2005-07-28
RU2362781C2 (ru) 2009-07-27
FI118084B (fi) 2007-06-29
NO950420D0 (no) 1995-02-06
RU2004106773A (ru) 2005-08-10
DK0676413T3 (da) 2005-05-09
ES2236696T3 (es) 2005-07-16
RU2004106774A (ru) 2005-08-10
RU2004106775A (ru) 2005-08-10
RU2232811C2 (ru) 2004-07-20
RU2336279C2 (ru) 2008-10-20
RU2363705C2 (ru) 2009-08-10
DE69533905T2 (de) 2005-12-29
EP0676413A3 (de) 1996-04-03
NO318912B1 (no) 2005-05-23
ATE286509T1 (de) 2005-01-15
UA46694C2 (uk) 2002-06-17
KR950032620A (ko) 1995-12-22
JP3670045B2 (ja) 2005-07-13
CA2141747C (en) 2012-05-01
DE69533905D1 (de) 2005-02-10
AU1141695A (en) 1995-08-17
AU688430B2 (en) 1998-03-12
KR100382628B1 (ko) 2004-02-25
EP0676413A2 (de) 1995-10-11
FI950516L (fi) 1995-08-08
IL108584A (en) 2008-03-20
IL108584A0 (en) 1994-05-30
NO950420L (no) 1995-08-08

Similar Documents

Publication Publication Date Title
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
IE811463L (en) Interferons
BR9405507A (pt) Adenovirus recombinante defeituoso linhagem celular e composição farmaceutica
FI971613A7 (fi) Defektiivisiä adenoviruksia, jotka käsittävät terapeuttisen geenin ja immunoprotektiivisen geenin
SE8105657L (sv) Mikrobiell framstellning av humanfibroblastinterferon
MY102472A (en) Preparation of funtional human urokinase proteins.
FI962247L (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DK568587A (da) Dna fragmenter indeholdende alkalisk cellulasegen, rekombinante plasmider indeholdende disse dna fregmenter og rekombinante mikroorganismer
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
AU2751392A (en) Vaccines for actinobacillus pleuropneumoniae
AU1141695A (en) Interferon-alpha/beta binding protein, its preparation and use
FI863626A7 (fi) DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä.
EP0749312A4 (de) DIROFILARIA IMMITIS - Gp29 - PROTEINE, NUKLEINSÄUREMOLEKÜLE UND IHRE VERWENDUNGEN
ATE128728T1 (de) Interferon-gamma bindende proteine.
ATE202570T1 (de) Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen
DE69903559D1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
AU590861B2 (en) New human lymphotoxin (TNF-beta) polypeptides their prepartion and use
AU8957091A (en) Immunoglobulin-binding proteins and recombinant dna molecules coding therefor
EP0723016A3 (de) Leukocyten-aktivierender Faktor
ZA979390B (en) Polypeptides comprising domains of the GAX protein which are involved in the repression of transcription and/or which interact with other proteins, corresponding nucleic acids and their uses.
AU571460B2 (en) Alpha interferon dna, recombinant plasmid, engineered organism and alpha interferon polypeptide
EP1019500A4 (de) Neue ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
FI964784L (fi) Yhdistelmä-DNA-viruksia, valmistus ja käyttö geeniterapiassa
IE882662L (en) Dna sequences, recombinant dna molecules for producing¹soluble t4 proteins